Nearly 1,500 New Zealand doctors and pharmacists have now registered on MCinfo.com – a dedicated and comprehensive medicinal cannabis...

David Darling has been appointed as an independent director on the board at Helius Therapeutics – New Zealand’s largest medicinal...

The medicinal cannabis sector is delivering for Kiwi patients. However, most of its successes continue to fly under the radar. This is...

New Zealand’s two largest medicinal cannabis companies have signed a supply contract that will provide Kiwis further access to locally...

This month marks three years since Parliament unanimously passed the legislation to enable a New Zealand medicinal cannabis industry....

A leading medicinal cannabis online education platform is encouraged by the strong interest it’s now seeing from New Zealand’s key...

Helius is pleased to announce that Angela Freiden has been appointed Director of Innovation & Productivity. As Director of Innovation &...

Two new kiwi manufactured medicinal cannabis medicines will be available on prescription from Thursday after the Medicinal Cannabis...

With the availability of highly desired local medicinal cannabis products fast approaching, healthcare professionals are being encouraged...

Under the Medicinal Cannabis Scheme, transitional arrangements for existing medicinal cannabis products in New Zealand will end on 30...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good...

A new study has added further scientific evidence that entourage effect – the synergistic nature of all the cannabis plant's compounds...

The endocannabinoid system (ECS) is a complex cell signalling system that plays a very important role in the human body, maintaining...

Joanna Perry MNZM has been appointed to the board of Helius Therapeutics, New Zealand’s largest licenced medicinal cannabis company. The...

Leading the development of some of the world’s first clinically trialled and registered cannabis medicines for pets, Hale Animal Health...

A new paper published by scientists at ESR has confirmed the cannabinoid content of New Zealand's illicitly-sourced medicinal cannabis...

Launched this week, New Zealand's medicinal cannabinoid information service is focused on delivering quality prescriber education...

"With over $100 million invested so far in New Zealand’s medicinal cannabis industry, 2021 is our year to shine,” says Dr Zahra Champion,...

Mark Morrison has been appointed Chief Commercial Officer at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, is delighted to be working closely with Plant & Food...